PredictCan Featured on BFM Business to Discuss the Future of Precision Medicine
PredictCan CEO and co-founder Dr. Hong Tuan Duong joined BFM Business to discuss how individual-centric preclinical models could help move precision medicine earlier into drug development and better account for patient diversity.
PredictCan Selected as a Boost Invest MedVallée Awardee
PredictCan Biotechnologies has been selected as a Boost Invest MedVallée awardee, recognizing the company’s scientific achievements, international development, and strategy for its next phase of growth.
PredictCan Named Among Five Precision Medicine Startups to Watch Worldwide
PredictCan Biotechnologies has been selected by StartUs Insights as one of five exemplary precision medicine startups, following the analysis of more than 600 companies worldwide.